No Data
No Data
No Data
No Data
No Data
RedHill Biopharma Advances COVID-19 Antiviral Study
TipRanksApr 24 19:57
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study Of RHB-107 (Upamostat), The Study Is Expected To Be Completed By The End Of 2024
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study Of RHB-107 (Upamostat), The Study Is Expected To Be Completed By The End Of 2024
BenzingaApr 24 19:06
323 drugs, hurry up! America is facing the biggest “drug shortage” in history...
The US now seems to be facing an unprecedented “drug shortage”...
cls.cnApr 15 14:37
RedHill Biopharma Full Year 2023 Earnings: EPS: US$4.00 (Vs US$46.29 Loss in FY 2022)
Yahoo FinanceApr 10 18:23
RedHill Biopharma's Strategic Pivot and Financial Turnaround
TipRanksApr 8 22:27
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
Selected for evaluation by two U.S. government countermeasures programs for Acute Radiation Syndrome (ARS) and Sulfur Mustard exposure.
Investing.com Apr 8 21:42
No Data
No Data